Navigation Links
WeissComm Partners Promotes Diane Weiser to President and Chief Operating Officer
Date:3/25/2008

NEW YORK and SAN FRANCISCO, March 25 /PRNewswire/ -- WeissComm Partners, Inc., the fastest growing independent public relations firm in the United States, today announced the promotion of Diane Weiser to President and Chief Operating Officer. She will continue to report to WeissComm's founder and CEO, Jim Weiss, who also will become Chairman.

Since Weiser joined WeissComm in August 2004, the firm has quadrupled its revenues to $16.5 million and the number of employees to more than 75, grown its New York office, opened offices in Chicago and Washington, D.C., and established an international presence and capability.

"Diane has successfully applied more than 20 years of healthcare communications experience to WeissComm's diverse portfolio of innovative biotechnology, pharmaceutical, healthcare services, device and diagnostic clients," Weiss said. "She has taken WeissComm to a higher level with her commitment to quality and preservation of our unique independent, entrepreneurial culture, her no-nonsense, direct management style, attention to detail and thoughtful infrastructure development. In this much-deserved new role, Diane will help lead WeissComm into our next exciting phase of growth and expansion."

Prior to joining WeissComm, Weiser was director of the healthcare practice in the San Francisco office of Ketchum. In that position, she led the Genentech Avastin(R) business, managing a multi-office Best Team for the account, as well as providing counsel to other Genentech product teams. Prior to Ketchum San Francisco, Diane ran Ketchum's New York healthcare practice, which was the lead agency for the global Lipitor(R) business. She has developed and managed strategic, high-profile programs for leading pharmaceutical and biotechnology companies including Pfizer, Roche, Bayer Diagnostics, Allergan, Aventis, Celgene Corporation and Pharmacia.

About WeissComm Partners

WeissComm Partners, Inc. is a full-service public relations agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. WeissComm's team of seasoned professionals specializes in healthcare marketing, corporate and product PR, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient PR programs. Ranked among the top independent PR firms in the United States, WeissComm serves clients globally with offices in San Francisco, New York, Chicago, and Washington, D.C., and in London via a strategic alliance with Resolute Communications. For more information, please visit http://www.wcpglobal.com.


'/>"/>
SOURCE WeissComm Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
2. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
3. Kagome Partners With Raise the Hope to Fight Heart Disease
4. HealthMEDX Partners With Silverchair Learning Systems
5. Turner Investment Partners Added to AHA Diversified Equity Fund
6. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
7. ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services
8. Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More
9. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... ... With millions of Americans and people worldwide struggling with ... aware of our options and are empowered with strength and information throughout the ... newest edition of "Vision and Hearing" in USA Today, that will educate readers ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users ... X . Users have total control over position, rotation, distortion, edge softness, edge blur, ... Final Cut Pro X. , With ProGlass Prism users are given the tools ...
(Date:2/24/2017)... IL (PRWEB) , ... February 24, 2017 , ... The ... the 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. ... Choice will be showcased and the winner revealed at the 31st annual iaedp Symposium, ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... and PETACH TIKVAH, Israel , ... (NASDAQ: BCLI), a leading developer of adult stem cell ... June S. Almenoff , M.D., Ph.D., FACP, and ... Board of Directors.  "Dr. Almenoff and ... appointments come at an exciting time for our company," ...
(Date:2/24/2017)... Following receiving CE Marking in ... AMAR is a major milestone for the country where the device was ... market in Israel   ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... Strategies - 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis and ... Hemophilia market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Hemophilia market? ...
Breaking Medicine Technology: